Preferred Label : cabotegravir;

MeSH note : an HIV integrase strand transfer inhibitor;

CISMeF synonym : GSK1265744;

MeSH synonym : (3S,11aR)-N-((2,6-difluoropyridin-3-yl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide;

MeSH hyponym : GSK744; N-((2,4-difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide; GSK-1265744B; sodium (3S,11aR)-8-(((2,4-difluorophenyl)methyl)carbamoyl)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo(3,2-a)pyrido(1,2-d)pyrazin-6-olate; S-265744B; GSK1265744B; Vocabria; Apretude; S-265744; GSK-1265744A; GSK-1265744; GSK1265744A;

MeSH Related Number : 3L12PT535M;

Is substance : O;

UNII : HMH0132Z1Q;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/apretude
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabotegravir
cabotegravir
cabotegravir
drug approval
europe
adult
adolescent
hiv infections
HIV-1
Pre-Exposure Prophylaxis
administration, oral
injections, intramuscular
Delayed-Action preparations
HIV integrase inhibitors
HIV integrase inhibitors
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3526084/fr/apretude-cabotegravir-vih-/-prep
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Delayed-Action preparations
injections, intramuscular
hiv infections
adult
adolescent
HIV-1
Sexual Transmission
cabotegravir
evaluation of the transparency committee
Pre-Exposure Prophylaxis
cabotegravir

---
https://www.has-sante.fr/jcms/p_3412898/fr/vocabria-cabotegravir-vih
2023
false
false
false
France
cabotegravir
treatment outcome
insurance, health, reimbursement
adult
HIV-1
hiv infections
anti-hiv agents
drug therapy, combination
HIV integrase inhibitors
evaluation of the transparency committee
cabotegravir

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vocabria
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabotegravir
cabotegravir
drug approval
europe
cabotegravir
HIV integrase inhibitors
HIV integrase inhibitors
drug antagonism
hiv infections
HIV-1
Rilpivirine
adult
administration, oral
injections, intramuscular
Delayed-Action preparations
Cabotegravir Sodium
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
cabotegravir
cabotegravir
pyridones
pyridones

---
https://www.has-sante.fr/jcms/p_3263063/fr/vocabria-cabotegravir
2021
false
false
false
France
cabotegravir
administration, oral
injections, intramuscular
treatment outcome
drug approval
guidelines for drug use
HIV-1
drug therapy, combination
hiv infections
adult
Rilpivirine
HIV integrase inhibitors
evaluation of the transparency committee
cabotegravir
cabotegravir
pyridones

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.